GGrantIndex
Sort

53,477 grants matching addiction

Telemedicine for Smoking Cessation in Rural Primary Care

$719,506
Kimber P Richter · University Of Kansas Medical Center · R01 · FY2010 · HL

Impact on opioid use of bundling medication-assisted treatment with mHealth

$719,353
David H Gustafson · University Of Wisconsin-Madison · R01 · FY2015 · DA

Inter-Temporal Trade-offs in the Risky Decisions of Cocaine Addicts

$719,325
Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2014 · DA

Drug Abuse Training Program

$719,276
Jacqueline F. McGinty · Medical University Of South Carolina · T32 · FY2018 · DA

Criminal Justice AddIction Treatment in Texas (CJATT)

$719,269
Kevin Knight · Texas Christian University · U01 · FY2006 · DA

Implementing a Community-Based Response to the Opioid Epidemic in Rural Ohio

$719,153
William C Miller · Ohio State University · UH3 · FY2019 · DA

Marketing, FDA communication, tobacco perceptions and use in addiction treatment

$719,137
Joseph R Guydish · University Of California, San Francisco · R01 · FY2013 · DA

Genetics of Brain Structure and Function

$719,101
John Blangero · Texas Biomedical Research Institute · R01 · FY2008 · MH

Assessing the Impact of Cannabis Legalization on Adolescent Cannabis Use and Cannabis-Related Health Conditions

$719,065
Kelly Corinne Young-Wolff · Kaiser Foundation Research Institute · R01 · FY2022 · DA

Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates

$719,019
Jack Bergman · Mclean Hospital · R01 · FY2021 · DA

An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology

$718,845
Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2022 · DA

Linking Russian Narcology and HIV Care to Enhance Treatment, Retention and Outcomes Part II

$718,780
Jeffrey H Samet · Boston Medical Center · R01 · FY2021 · DA

The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency

$718,779
Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2020 · DA

Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial

$718,669
Brandon David Lewis Marshall · Brown University · R01 · FY2019 · DA

Long-Term Abstinence Clinical Issues and CNS Disinhibition

$718,656
George Fein · Neurobehavioral Research, Inc. · R01 · FY2008 · AA

Project 4: A Naturalistic Observation of Electronic Cigarettes and Oral Nicotine Pouch Product Use Among Adolescents and Young Adults

$718,631
Amy K Ferketich · Ohio State University · U54 · FY2023 · CA

Randomized trial of a data-driven technical assistance system for drug prevention coalitions

$718,579
Louis Davis Brown · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · DA

Lasting Neurological Effects of Perinatal Opioids

$718,566
Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2024 · DA

Lasting Neurological Effects of Perinatal Opioids

$718,566
Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2023 · DA

Twin Family Study of Vulnerability to Substance Abuse

$718,505
William G Iacono · University Of Minnesota · R37 · FY2016 · DA

Center to Improve System Performance of Substance Use Disorder Treatment

$718,463
Constance M Horgan · Brandeis University · P30 · FY2017 · DA

Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates

$718,402
Jack Bergman · Mclean Hospital · R01 · FY2022 · DA

Neuroeconomics of Drug Addiction

$718,400
Michael Platt · Duke University · P30 · FY2010 · DA

Synergistic Effect of Nicotine and Antiretrovirals on Placental Development

$718,374
Aditya N Bade · University Of Nebraska Medical Center · R01 · FY2025 · DA

NMDA receptor modulation for hyperarousal in PTSD

$718,188
Sanjay J Mathew · Baylor College Of Medicine · R61 · FY2016 · MH